Skip to main content
. 2020 Feb 6;10:80. doi: 10.3389/fonc.2020.00080

Figure 4.

Figure 4

(A,B) Kaplan–Meier estimates of BCFI and ever MHT use stratified by ever AI treatment. (C,D) Kaplan–Meier estimates of OS and ever MHT use stratified by ever AI treatment. (E,F) Kaplan–Meier estimates of BCFI and ever MHT use stratified by ever tamoxifen treatment. (G,H) Kaplan–Meier estimates of OS and ever MHT use stratified by ever tamoxifen treatment. The number of patients is indicated at each follow-up. The study is ongoing; thus, the number of patients decreases with each follow-up.